Origin and manufacturer of Bituva/Bikernopinol tablets

Biktarvy is an anti-HIV compound preparation widely used around the world. Its original drug is developed and produced by Gilead Sciences, an internationally renowned pharmaceutical company. Gilead, headquartered in California, USA, is a leading R&D company in the field of antiviral drugs. Its product lines cover HIV (AIDS), hepatitis B, hepatitis C and other infectious diseases. Specific to Bikeren Prena tablets, its commercial production and some internationally distributed versions of the drug are produced in Canada, so the origin marked on many outer packages is "Canada". Its production plant is completed in Gilead's GMP certified facilities in North America. The entire process from raw material extraction to preparation processing is managed and complies with international pharmaceutical quality standards.

Globally,Gilead has standardized the supply channels of Bikrona tablets. For different countries and regions, drug registration, label language, and outer packaging style will be customized according to local regulatory requirements. For example, the versions exported to regions such as Hong Kong, China, mostly have English labels on the outer packaging, and the origin is mostly stated as Canada, reflecting their supply chain model of production in North America and then exporting. At present, regular pharmacies have launched the original drug Bikernprenol Tablets for sale in the Chinese mainland market.

In addition,Gilead also authorizes generic drug manufacturers in certain low-income countries to produce generic versions of Bikeren Prena tablets to achieve accessibility and equity in the global prevention and treatment of HIV. However, it should be noted that most of these counterfeit versions are only sold in specific regions and cannot be legally circulated in mainland China. For domestic patients, if they need to use Bikern Prenol Tablets for antiviral treatment, common channels include going abroad for medical treatment, obtaining prescription support from international medical platforms, or purchasing original drugs at their own expense through legal cross-border drug purchase.

Reference materials:https://www.biktarvy.com/